Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/03/15 | UPLOAD | SEC-generated letter |
|
3 | |
| 01/20/15 | 8-K | Current report filing |
|
3 | |
| 01/16/15 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
5 | |
| 01/14/15 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
120 | |
| 01/09/15 | 8-K/A | Current report filing |
|
68 | |
| 01/08/15 | 8-K | Current report filing |
|
3 | |
| 01/06/15 | 8-K | Current report filing |
|
10 | |
| 01/05/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/11/14 | UPLOAD | SEC-generated letter |
|
1 | |
| 11/24/14 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
5 |
